1. Home
  2. NWTG vs BOLT Comparison

NWTG vs BOLT Comparison

Compare NWTG & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

N/A

Current Price

$1.11

Market Cap

6.2M

ML Signal

N/A

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$3.67

Market Cap

7.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
BOLT
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
7.1M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
NWTG
BOLT
Price
$1.11
$3.67
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $29.00
AVG Volume (30 Days)
★ 64.8K
31.2K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.09
N/A
EPS
★ N/A
N/A
Revenue
★ $8,135,000.00
$7,695,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$104.02
$2,525.07
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 136.14
0.07
52 Week Low
$0.70
$3.10
52 Week High
$1.97
$7.20

Technical Indicators

Market Signals
Indicator
NWTG
BOLT
Relative Strength Index (RSI) N/A 47.24
Support Level N/A $3.13
Resistance Level N/A $4.34
Average True Range (ATR) 0.00 0.32
MACD 0.00 -0.00
Stochastic Oscillator 0.00 40.48

Price Performance

Historical Comparison
NWTG
BOLT

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Share on Social Networks: